LONDON, Feb 26 (Reuters) - GlaxoSmithKline said onThursday that its chairman-designate Philip Hampton would takecharge of Britain's biggest drugmaker from May 7, marking anearlier transition than initially anticipated.
Hampton, who chairs Royal Bank of Scotland, wasnamed as the pharmaceutical company's next chairman lastSeptember, but GSK said at the time he might not take up theposition until Sept. 1, 2015, if he could not be released fromother commitments. (Reporting by Ben Hirschler; Editing by Greg Mahlich)